Nectar Lifesciences Limited — Important, 06-08-2025: Updates

Nectar Lifesciences shareholders approved key proposals at its Extraordinary General Meeting. They approved the appointment of Dr. Surulichamy Senthilkumar as a Director and as a Whole-time Director (R&D) for three years. Critically, shareholders also greenlit the transfer of the company's business to Ceph Lifesciences Private Limited on a 'slump sale' basis as a going concern. This strategic move could streamline operations or unlock value for the company. Voting results will be released separately.